Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner.

作者: Jason R Richardson , W Michael Caudle , Min Zheng Wang , E Danielle Dean , Kurt D Pennell

DOI: 10.1016/J.NEURO.2008.05.007

关键词:

摘要: Abstract Parkinson's disease (PD) is primarily thought of as a aging. However, recent evidence points to the potential for exposure xenobiotics during development increase risk PD. Here, we report that developmental organochlorine pesticide heptachlor alters dopamine system and increases neurotoxicity in an animal model Exposure pregnant mice led increased levels transporter (DAT) vesicular monoamine 2 (VMAT2) at both protein mRNA level their offspring. Increased DAT VMAT2 were accompanied by alterations nuclear transcription factors control neuron regulate adulthood. At 12 weeks age, heptachlor-exposed offspring administered moderate dose (2× 10 mg/kg) parkinsonism-inducing agent MPTP. Greater evidenced greater loss striatal potentiation glial fibrillary acidic α-synuclein was observed The male than female offspring, suggesting males are more susceptible long-term effects exposure. These data suggest causes thereby rendering it dopaminergic damage

参考文章(55)
Rocco Di Paola, Ryan J. Uitti, Early Detection of Parkinson??s Disease Drugs & Aging. ,vol. 9, pp. 159- 168 ,(1996) , 10.2165/00002512-199609030-00002
Kenneth Reuhl, Delayed expression of neurotoxicity: the problem of silent damage. Neurotoxicology. ,vol. 12, pp. 341- 346 ,(1991)
D B Baker, J Barker, S Loo, Evaluation of human exposure to the heptachlor epoxide contamination of milk in Hawaii. Hawaii medical journal. ,vol. 50, pp. 108- 118 ,(1991)
Sadik A. Khuder, Snigdha Shrivastava, Anumeet Priyadarshi, Eric A. Schaub, A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. ,vol. 21, pp. 435- 440 ,(2000)
Jennifer L Tillerson, W Michael Caudle, Maria E Reverón, Gary W Miller, None, Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Experimental Neurology. ,vol. 178, pp. 80- 90 ,(2002) , 10.1006/EXNR.2002.8021
M. Park, G. W. Ross, H. Petrovitch, L. R. White, K. H. Masaki, J. S. Nelson, C. M. Tanner, J. D. Curb, P. L. Blanchette, R. D. Abbott, Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. ,vol. 64, pp. 1047- 1051 ,(2005) , 10.1212/01.WNL.0000154532.98495.BF
Jaime M Hatcher, Jason R Richardson, Thomas S Guillot, Alison L McCormack, Donato A Di Monte, Dean P Jones, Kurt D Pennell, Gary W Miller, None, Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system Experimental Neurology. ,vol. 204, pp. 619- 630 ,(2007) , 10.1016/J.EXPNEUROL.2006.12.020